FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to organic chemistry, namely to a heterocyclic compound of formula I and its pharmaceutically acceptable salt, wherein if a chemical valency permits, i represents 1 or 2, R1 represents H; a linear (C1-C4) alkyl group, R2 represents H, Cl or F, X represents either N, or CR3, R3 represents H; halogen; a linear (C1-C4) alkyl or (C1-C4) alkoxyl group, Y represents Z represents O or NRx, Rx represents H or a linear or branched (C1-C4) alkyl, k is equal to 2, 3 or 4, n and p independently represents 2, and a sum of n+p cannot exceed 4, T represents H or a linear (C1-C4) alkyl group; T′ represents a linear C1-C3 alkyl chain substituted by either (C1-C6)-dialkylaminogroup, or a 5-6-merous saturated heterocycle containing one nitrogen atom and optionally containing the second heteroatom specified in O, such a heterocyclic ring is optionally substituted by a (C1-C4) alkyl chain at nitrogen atoms; or a 5-merous saturated heterocycle containing one nitrogen atom, such a heterocyclic ring is optionally substituted by a (C1-C4) alkyl chain at nitrogen atoms; r represents zero, 1; R′ represents di(C1-C4)alkylamino, (C1-C4)alkoxy; except for the compounds specified in the clause. The invention also refers to a pharmaceutical composition based on the compound of formula (I), using the compound of formula (I) and to a method of treating diseases, in which the hedgehog signalling pathway modulation is effective.
EFFECT: there are prepared new heterocyclic compounds possessing t effective biological properties.
20 cl, 193 ex
Title | Year | Author | Number |
---|---|---|---|
BENZIMIDAZOLE, BENZOTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND USE THEREOF AS LTA4H MODULATORS | 2004 |
|
RU2373204C2 |
BICYCLIC IMIDAZOL DERIVATIVES AS MEDIUM AGAINST VIRUSES OF FLAVIVIRIDAE FAMILY | 2004 |
|
RU2355687C2 |
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
NOVEL BENZODIOXOLS | 2003 |
|
RU2304580C2 |
POLYHETEROCYCLIC COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | 2005 |
|
RU2381226C2 |
PYRROLO[2,3-c]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2385320C2 |
CYCLIC AZAINDOLE-3-CARBOXAMIDE, PRODUCTION AND USE THEREOF AS THERAPEUTIC PREPARATIONS | 2009 |
|
RU2487874C2 |
ALLOSTERIC MODULATORS OF METABOLIC GLUTAMATE RECEPTORS | 2004 |
|
RU2360902C2 |
DERIVATIVES OF 1-(4-BENZYLPIPERAZIN-1-YL)-3-PHENYLPROPENONE AND THEIR USE, PHARMACEUTICAL COMPOSITION AND METHOD INHIBITING CHEMOKINE RECEPTORS (CCR-1) | 2003 |
|
RU2347782C2 |
Authors
Dates
2014-11-20—Published
2010-06-09—Filed